NDAT.CN nDatalyze Corp. (CNQ) up 50% Feb 04 2026: volume surge hints momentum

The NDAT.CN stock popped 50.00% to C$0.03 on Feb 04 2026 during market hours on the CNQ exchange, making it one of today’s top gainers in Canada. The move came on light volume of 4,000 shares versus an average volume of 5,951, and pushed price above the 50-day average of C$0.0172. Traders flagged the bounce as a liquidity-driven spike rather than an earnings surprise, since the company shows no upcoming earnings announcement.

NDAT.CN stock intraday move and trading stats

NDAT.CN stock closed at C$0.03, a +50.00% change from the previous close of C$0.02, with a day high and low of C$0.03; reported volume was 4,000 shares and average volume is 5,951. The market cap stands at C$1,239,822 and shares outstanding are 41,327,400, which creates a small-cap, low-liquidity profile that amplifies price swings.

NDAT.CN stock drivers and company update

There was no new earnings release or press filing tied to this move; nDatalyze Corp. develops a machine-learning mental health app and sells CO2 extraction equipment for medical cannabis growers. The jump appears driven by thin float dynamics and short-term trading interest rather than fresh fundamental news.

NDAT.CN stock valuation and key financials

NDAT.CN shows EPS of -0.02 and a reported PE of -1.50, reflecting negative earnings. The price-to-book ratio is 2.47, book value per share is C$0.01, and cash per share is C$0.01, while the 50-day average price is C$0.0172 and the 200-day average is C$0.01608, which places today’s price above both averages but still at penny-stock levels.

NDAT.CN stock technicals and market structure

Technical signals are limited by sparse trading; relative volume was 0.67 and on-chart indicators are mostly flat or unavailable. The stock’s low float and wide bid-ask spreads increase volatility, so intraday momentum can persist or reverse quickly depending on a few trades.

NDAT.CN stock risks, sector context and analyst signals

As a Healthcare company in Medical – Healthcare Information Services, NDAT.CN faces sector headwinds where average peers show positive margins; nDatalyze posts negative margins and stretched receivables. A company rating dated 2026-02-02 shows a C+ grade with mixed metric signals and a sell-oriented recommendation from some sources, highlighting execution and liquidity risk.

Meyka AI grade and NDAT.CN stock forecast

Meyka AI rates NDAT.CN with a score out of 100: 58.87 (C+) — SUGGESTION: HOLD. This grade factors S&P 500 and sector comparisons, financial growth, key metrics, forecasts, and analyst consensus. Meyka AI’s forecast model projects a short-term target of C$0.06, implying an estimated upside of 100.00% versus the current C$0.03, while noting that forecasts are model-based projections and not guarantees.

Final Thoughts

NDAT.CN stock was the session’s top gainer on Feb 04 2026 after a 50.00% intraday rise to C$0.03, driven by low liquidity and short-term trading flows on the CNQ exchange in Canada. Fundamentals remain weak: EPS -0.02, negative margins, and high days-sales-outstanding raise execution risk. Technicals show a price above the 50- and 200-day averages but thin average volume (5,951) limits signal reliability. Meyka AI rates the company 58.87/100 (C+) and models a cautious target of C$0.06 — an implied 100.00% upside from today’s price — yet we stress forecasts are not guarantees. For traders, NDAT.CN suits high-risk, speculative positions sized to limit downside; for longer-term investors, improved revenues or clearer product traction would be necessary before upgrading conviction. Meyka AI, our AI-powered market analysis platform, flags liquidity and fundamental risks alongside the short-term upside.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.